Generic Severe Chronic Pain Treatment Launched


Generic tramadol hydrochloride extended-release tablets treat moderate to moderately severe chronic pain.

Mylan is launching tramadol hydrochloride extended-release tablets—a generic version of Valeant’s Ultram extended-release tablets.

The FDA approved Mylan’s abbreviated new drug application for the product, which can be used to treat moderate to moderately severe chronic pain in adults who need around-the-clock pain treatment for an extended period of time.

Mylan also has 265 abbreviated new drug applications pending FDA approval.

Tramadol hydrochloride extended-release tablets USP, 100 mg, 200 mg, and 300 mg, brought in US sales of around $52.8 million in 2015, according to IMS Health.

Aurobindo Pharma Limited also announced back in October 2015 that it had received final approval from the FDA to manufacture and market a generic version of Ultram.

Related Videos
Young depressed woman talking to lady psychologist during session, mental health - Image credit: motortion |
man taking opioid pills sitting at a dark table - Image credit: rohane |
schizophrenic man - mental disorder - Image credit: Andreza |
Aimee Keegan, PharmD, BCOP, a clinical pharmacist
A panel of 3 experts on hepatic encephalopathy
A panel of 3 experts on hepatic encephalopathy
© 2024 MJH Life Sciences

All rights reserved.